ALLIANCE ENTERTAINMENT HOLDING CORP
AENTInvestment snapshot
Positive
1
BUY / PASS
Neutral / negative
2 / 13
NEUTRAL / FAIL
Median fair value
$3.78
-23.6% vs price
Models with upside
1 / 17
Positive margin of safety
Key risk
All 8 investors flag AENT's growth
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | BUY ยท Rank #225 (Top 7.3%) | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ | Checking accessโฆ |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | -33.5% | -4.7% | N/A | -28.3% | N/A | -43.2% | -13.0% | -125.6% | +19.1% | -199.4% | -13.8% | -199.4% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Annual history ยท FY 2024 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท Balance sheet at 2026-09-30 ยท TTM ended 2026-09-30 vs 2025-09-30 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 Latest source filing: 2025-09-10 Score computed: 2026-11-14 | Annual history ยท FY 2024 Latest source filing: 2025-09-10 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Market data at 2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Qualitative assessment ยท Annual history ยท FY 2024 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Qualitative assessment ยท Annual history ยท FY 2024 Latest source filing: 2025-09-10 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท Qualitative assessment ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท TTM ended 2026-09-30 ยท Qualitative assessment Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Market data at 2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท Price history 2025-01-01โ2026-11-01 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท Qualitative assessment Latest source filing: 2025-09-10 Score computed: 2026-11-14 | TTM ended 2026-09-30 ยท Balance sheet at 2026-09-30 ยท Price history 2025-01-01โ2026-11-01 ยท Annual history ยท FY 2024 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history ยท FY 2024 ยท Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | TTM ended 2026-09-30 ยท Annual history ยท FY 2024 ยท Price history 2025-01-01โ2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Growth0% passโ 13โพ
All 8 investors flag AENT's growth
EPS Growth (3-yr avg, 10-yr window)โGraham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 16.5x (growth N/A)โLynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-20.6%โLynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 24.9% vs Rev: -66.4%โLynchInventory growth < Revenue growthEPS Growth Direction$0.60 (2021) -> $0.30 (2024)โDremanPositive over recent yearsEPS CAGR-20.6% CAGR over 3 yearsโDreman> 5% annualizedPositive Net Income Frequency3/4 years positiveโMarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-67.9%โAckman>= 5%Positive EPS Growth Frequency2/3 years with positive EPS growthโAckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR-20.6% CAGR over 3 yearsโTempleton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 50.6% -> 100.0%, operating margin -194.9% -> 1116.1%โSleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGRโSleepCAGR > 7%3-5 Year Diluted EPS CAGR-20.6% over 3 yearsโNeff7%-20% annualized - Profitability6% passโ 9โ 26โพ
15 of 16 flag AENT's profitability โ Graham, Buffett, Lynch +12 more
Net income / market capitalization+6.28%; #1343/6340 (top 21.2%)โAsnessTop 30% of eligible cross-sectionโOshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)3/5 years positiveโGrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)โGraham>= 33% growthNet Income Positive (10+ years)3/5 years positiveโBuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)0.4%โBuffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)1116.1% (latest)โBuffettStable or rising over 10 yearsFree Cash Flow Proxy$20.4MโBuffettPositive and growingEarnings Variance (10-yr CoV)โBuffettCoV < 0.3Retained Earnings EffectivenessโBuffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 16.5x (growth N/A)โLynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-20.6%โLynch15-30% (Fast Grower); > 0% to passROE12.7%โLynch> 15%EBIT / Enterprise Value9.8%โGreenblatt> 10%Earnings Yield + ROC AssessmentEY=9.8%, ROC=54.3%โGreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets4.17%โPiotroskiROA > 0ROA Change YoY1.34% -> 4.17% (delta: +2.83%)โPiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.42%, ROA=4.17%โPiotroskiCFO/Assets > ROAGross Margin Change YoY88.1% -> 100.0%โPiotroskiImproved YoYPre-Tax Income / Revenue8.0%โDreman>= 8%Net Income / Shareholders' Equity12.7%โDreman> 12%Margin of SafetyP/E=16.5x, P/B=2.4xโPabraiP/B < 1.5 or P/E < 15Return on Equity-8.2% (3-yr avg)โAkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)โMarks>= 20% below intrinsic valuePositive Net Income Frequency3/4 years positiveโMarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue9.7%โAckman>= 15%Net Income / Shareholders Equity12.7%โAckman>= 15%5-Year EPS CAGR-20.6% CAGR over 3 yearsโTempleton> 0% (5-year EPS CAGR)Operating Margin Trend-194.9% (2022) -> 1116.1% (2024)โTempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 50.6% -> 100.0%, operating margin -194.9% -> 1116.1%โSleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+0.75%; #3374/3702 (top 91.1%)โAsnessTop 30% of eligible cross-sectionNet income / positive book equity+12.70%; #1430/5226 (top 27.4%)โAsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0585; #2780/5884 (top 47.2%)โAsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR-20.6% over 3 yearsโNeff7%-20% annualizedPositive Diluted-EPS YearsโSchloss>= 70% positive over 5-10 observed years (app rule) - Debt & Leverage8% passโ 1โ 14โพ
11 of 12 flag AENT's debt & leverage โ Graham, Buffett, Lynch +8 more
LT Debt vs Net Current AssetsโGrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 1.13, IC: 6.1xโBuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity1.13โLynch< 0.33Cash - Long-term DebtโLynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%โPiotroskiDecreased YoYCurrent Assets / Current Liabilities1.32โDreman> 1.5โSchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity1.13โDreman< 0.8โTempleton< 1.0 (fixed cap; proxy for below-sector-median leverage)โSchlossD/E < 1.00xDebt Levels1.13โMungerDebt/Equity < 0.5โAkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=6.1x, D/EBITDA=4.8xโMarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity1.13โAckman<= 1.0Negative debt-to-equity (higher means less debt)-1.1300; #3346/4210 (top 79.5%)โAsnessTop 30% of eligible cross-section - Valuation models10% passโ 1โ 9โพ
Models split on AENT at $4.94 โ fair values range $1.65โ$6.11
Graham fair value$3.70โGraham-33.5% margin vs $4.94Buffett fair value$4.72โBuffett-4.7% margin vs $4.94Greenblatt fair value$3.85โGreenblatt-28.3% margin vs $4.94Dreman fair value$3.45โDreman-43.2% margin vs $4.94Munger fair value$4.37โMunger-13.0% margin vs $4.94Pabrai fair value$2.19โPabrai-125.6% margin vs $4.94Akre fair value$6.11โAkre+19.1% margin vs $4.94Marks fair value$1.65โMarks-199.4% margin vs $4.94Ackman fair value$4.34โAckman-13.8% margin vs $4.94Templeton fair value$1.65โTempleton-199.4% margin vs $4.94 - Efficiency13% passโ 2โ 9โพ
7 of 8 flag AENT's efficiency โ Graham, Buffett, Piotroski +4 more
Current Ratio1.32โGraham>= 2.0ROIC (3-5 yr avg)5.3%โBuffett> 10%ROIC - WACC-4.7%โBuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)54.3%โGreenblatt> 25%Current Ratio Change YoY1.33 -> 1.26โPiotroskiIncreased YoYRevenue / Total Assets Change YoY0.02x -> 0.01xโPiotroskiImproved YoYCurrent Assets / Current Liabilities1.32โDreman> 1.5Return on Invested Capital8.1%โMunger> 15%ROIC (high and growing)FY2022: ROIC=-11.8%; FY2023: ROIC=4.9%; FY2024: ROIC=14.7%โAkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC14.7% (RR=100% x ROIC=14.7%)โAkreReinvestment Rate * ROIC > 10%ROIC (5-year)2/4 years above 12% (latest 14.7%)โSleepROIC > 12% in a majority of years - Verdicts13% passโ 2โ 13โพ
Split decision: 13 FAIL ยท 2 NEUTRAL ยท 1 PASS
Overall verdictโGrahamFAIL (1/9)โBuffettFAIL (1/9)โLynchFAIL (0/7)โGreenblattRank #225โขPiotroskiNEUTRAL (F-Score 7)โDremanFAIL (1/11)โMungerFAIL (1/4)โPabraiFAIL (1/3)โAkreFAIL (2/6)โMarksFAIL (1/5)โAckmanFAIL (1/9)โTempletonFAIL (2/8)โSleepPASS (3/6)โAsnessFAIL (Rank #1668/2370 (Top 70.4%))โNeffFAIL (0/6)โSchlossFAIL (0/7)โขOshaughnessyNEUTRAL (Not ranked) - Valuation23% passโ 4โ 24โพ
10 of 13 flag AENT's valuation โ Graham, Lynch, Greenblatt +7 more
Net income / market capitalization+6.28%; #1343/6340 (top 21.2%)โAsnessTop 30% of eligible cross-sectionโOshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPSโGraham<= 15xPrice-to-Book Ratio2.4xโGraham<= 1.5xP/E x P/BโGraham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 16.5x (growth N/A)โLynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value9.8%โGreenblatt> 10%Earnings Yield + ROC AssessmentEY=9.8%, ROC=54.3%โGreenblattBoth EY > 10% and ROC > 25%Price / EPS16.5xโDreman< 12xโTempleton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)9.4xโDreman< 8xPrice / Book Value per Share2.4xโDreman< 1.2xโTempleton< 1.5xโSchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=16.5x, OE Yield=8.1%โMungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=16.5x, FCF Yield=10.6%โPabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=16.5x, P/B=2.4xโMarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)โMarks>= 20% below intrinsic valuePrice / FCF per Share9.4xโAckman<= 25Price vs. Trailing Low175% of trailing low ($2.83)โTempleton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.4944; #2911/6449 (top 45.1%)โAsnessTop 30% of eligible cross-sectionPrice / Diluted EPS16.5xโNeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/EโNeff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per ShareN/A (non-positive TBVPS)โSchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-11.7%โSchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.1148; #1649/5247 (top 31.4%)โOshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-0.42%; #2602/4519 (top 57.6%)โOshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-18.48%; #3890/6202 (top 62.7%)โOshaughnessyTop 10% of eligible cross-section - Cash Flow40% passโ 6โ 6โพ
6 of 10 flag AENT's cash flow โ Buffett, Lynch, Dreman +3 more
Free Cash Flow Proxy$20.4MโBuffettPositive and growingFCF Positive and Growing$-1.1MโLynchPositive and growingOperating Cash Flow$26.8MโPiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.42%, ROA=4.17%โPiotroskiCFO/Assets > ROAPrice / (CFO / Shares)9.4xโDreman< 8xP/E or FCF YieldP/E=16.5x, FCF Yield=10.6%โPabraiP/E < 15 or FCF Yield > 10%FCF Positive3/4 years FCF positiveโMarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-0.4%โAckman>= 4%Price / FCF per Share9.4xโAckman<= 25Positive Operating Cash Flow frequency3/4 years positiveโSleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-1.1MโNeff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-0.42%; #2602/4519 (top 57.6%)โOshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Retired 0.0% of shares last year, 3.6% issued over two.
- Buybacks
- โ
- Dividends
- โ
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total โ the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income รท EPS โ not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycleโs quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM ยท 2026-09-30 2025-10-01 โ 2026-09-30 Sources ยท derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, revenue, net income, operating income, ebit, pre tax income, interest expense. | Q1 FY 2027 2026-07-01 โ 2026-09-30 Sources | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|---|---|
| Market Cap | $251.7Mcurrent | -- | $335.3Mest. | $68.8Mest. | $515.3Mest. | $464.5Mest. | -- |
| Revenue | $280.6Mโ66% | $278.8Mโ31949% | $2.7Mโ68% | $8.4Mโ50% | $16.8Mโ99% | $1.4B | -- |
| Operating Income | $27.3Mโ29% | $10.6Mโ1% | $30.1Mโ113% | $14.1Mโ143% | -$32.7Mโ178% | $42.1M | -- |
| Net Income | $15.8Mโ19% | $7.6Mโ56% | $15.1Mโ229% | $4.6Mโ113% | -$35.4Mโ224% | $28.6M | -- |
| EPS (Diluted) | -- | $0.15โ50% | $0.30โ233% | $0.09โ112% | $-0.74โ223% | $0.60 | -- |
| Gross Margin | โ | โ | 100.0%โ14% | 88.1%โ74% | 50.6%โ293% | 12.9% | โ |
| Operating Margin | 9.7%โ111% | 3.8%โ100% | 1116.1%โ563% | 168.3%โ186% | -194.9%โ6663% | 3.0% | โ |
| ROE | 12.7%โ30% | โ | 14.6%โ179% | 5.2%โ112% | -44.5%โ269% | 26.3% | โ |
| Total Debt | $140.6Mโ138% | $140.6Mโ138% | $58.3Mโ59% | $142.6Mโ2% | $140.0M | $139.3Mโ23124% | $600.0K |
| Shareholders' Equity | $124.4Mโ15% | $124.4Mโ15% | $103.2Mโ18% | $87.6Mโ10% | $79.5Mโ27% | $108.9Mโ36% | $80.3M |
| Current Ratio | 1.32โ3% | 1.32โ3% | 1.26โ5% | 1.33โ53% | 0.87โ15% | 1.02โ23% | 0.83 |
| Debt / Equity | 1.13โ107% | 1.13โ107% | 0.57โ65% | 1.63โ8% | 1.76โ38% | 1.28โ17021% | 0.01 |
| Operating Cash Flow | -$133.0Kโ100% | $4.3Mโ58% | $26.8Mโ52% | $55.8Mโ1546% | $3.4Mโ104% | -$83.6M | -- |
| Free Cash Flow | -$1.1Mโ103% | $4.1Mโ72% | $26.8Mโ52% | $55.6Mโ2069% | $2.6Mโ103% | -$83.6M | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Wholesale
AENT vs Peers โ Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCKESSON CORPMCK | $127.3B | $1102.81 | $403.4B | $4.8B | -219.2% | -3.00 | 1.5% | 0.85 | 2/9 | 5/9 | 4/7 | 0/3 | F-Score 6 | 1/11 |
| W.W. GRAINGER, INC.GWW | $69.7B | $1489.30 | $17.9B | $1.7B | 45.7% | 0.67 | 13.9% | 2.83 | 4/9 | 6/9 | 4/7 | 1/3 | F-Score 6 | 5/11 |
| CARDINAL HEALTH INCCAH | $65.0B | $281.10 | $254.2B | $1.7B | -59.5% | -3.08 | 1.0% | 0.88 | 2/9 | 3/9 | 3/7 | 0/3 | F-Score 8 | 1/11 |
| SYSCO CORPSYY | $38.0B | $77.10 | $81.4B | $1.8B | 99.9% | โ | 3.8% | 1.21 | 3/9 | 5/9 | 5/7 | 1/3 | F-Score 4 | 2/11 |
| RELIANCE, INC.RS | $21.8B | $427.33 | $14.3B | $739.4M | 10.3% | 0.20 | 7.1% | 4.88 | 4/9 | 7/9 | 3/7 | 0/3 | F-Score 5 | 5/11 |
| WATSCO INCWSO | $12.8B | $308.46 | $7.2B | $497.0M | 17.9% | 0.17 | 10.0% | 4.12 | 5/9 | 7/9 | 4/7 | 1/3 | F-Score 6 | 8/11 |
| APPLIED INDUSTRIAL TECHNOLOGIES INCAIT | $10.9B | $297.60 | $4.6B | $393.0M | 21.3% | 0.31 | 10.9% | 3.32 | 6/9 | 5/9 | 4/7 | 1/3 | F-Score 5 | 7/11 |
| POOL CORPPOOL | $7.7B | $216.20 | $5.3B | $406.4M | 34.3% | 1.01 | 11.0% | 2.24 | 3/9 | 6/9 | 4/7 | 1/3 | F-Score 5 | 6/11 |